FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366285248> ?p ?o ?g. }

• W4366285248 endingPage "2916" @default.
• W4366285248 startingPage "2916" @default.
• W4366285248 abstract "Invasive lobular carcinoma accounts for 10 to 15% of all breast cancers. The first objective of this retrospective study was to assess the diagnostic performance of FDG-PET/CT scanning in women previously treated for invasive lobular carcinoma with suspected first recurrence. The secondary objectives were to evaluate the impact of PET/CT in a change in treatment and its prognostic value on specific survival.Patients in whom a PET/CT scan was performed from January 2011 to July 2019 in our Cancer Research Center were enrolled. Recurrence was suspected based on clinical symptoms, abnormal findings on conventional imaging, and/or elevated tumor markers. The diagnosis of recurrence was established by the oncologist after integration of all clinical, biological, histological, imaging, and follow-up data. Prognostic factors of recurrence as predicted by PET were determined using univariate logistic regression. KI67, mitotic index, or grade of mitosis were tested. Survival curves were compared using the log-rank test. Sixty-four patients (mean age: 60.3; SD = 12.4 years) were enrolled. The average time from initial diagnosis of the primary tumor to suspicion of recurrence was 5.2 ± 4.1 years. Forty-eight patients (75%) were judged to have recurrence by the oncologist: 7 local and 41 metastatic, with mainly bone (n = 24), lymph node (n = 14) and liver (n = 10) metastases.Sensitivity, specificity, and positive and negative predictive values of PET/CT to predict recurrence were, respectively: 87%, 87%, 95%, and 70%. SUVmax at recurrence sites was generally high (mean: 6.4; SD = 2.9). False negative PET/CT results occurred with local (n = 2), peritoneal (n = 2), meningeal (n = 1), or bladder (n = 1) recurrences. In 40 patients with available histopathological data from suspected sites of recurrence, 30 PET/CT were true positive. In four patients, primary lung (n = 1) or gastric (n = 1) tumors or lymphomas (n = 2) were found. The detection of a recurrence resulted in a change in treatment in 44/48 patients (92%). No association between recurrence predicted by PET and biological biomarkers was found. Median specific survival appears shorter in patients with metastatic recurrence versus patients with local or no recurrence on PET/CT (p = 0.067).FDG-PET/CT is an effective and reliable tool for the detection of invasive lobular carcinoma recurrence, although certain recurrence sites specific to this histological type can impair its diagnostic performance." @default.
• W4366285248 created "2023-04-20" @default.
• W4366285248 creator A5015775146 @default.
• W4366285248 creator A5015898602 @default.
• W4366285248 creator A5024817403 @default.
• W4366285248 creator A5059810021 @default.
• W4366285248 creator A5076128141 @default.
• W4366285248 creator A5078065507 @default.
• W4366285248 creator A5081409183 @default.
• W4366285248 date "2023-04-17" @default.
• W4366285248 modified "2023-09-26" @default.
• W4366285248 title "Performance of [18F]FDG-PET/CT Imaging in First Recurrence of Invasive Lobular Carcinoma" @default.
• W4366285248 cites W1526220176 @default.
• W4366285248 cites W1533336328 @default.
• W4366285248 cites W1696201675 @default.
• W4366285248 cites W1886195314 @default.
• W4366285248 cites W1898818310 @default.
• W4366285248 cites W1946183780 @default.
• W4366285248 cites W1955405862 @default.
• W4366285248 cites W1999547551 @default.
• W4366285248 cites W2027421309 @default.
• W4366285248 cites W2034073716 @default.
• W4366285248 cites W2037308967 @default.
• W4366285248 cites W2048939997 @default.
• W4366285248 cites W2064404596 @default.
• W4366285248 cites W2072871696 @default.
• W4366285248 cites W2101372043 @default.
• W4366285248 cites W2102541603 @default.
• W4366285248 cites W2117243051 @default.
• W4366285248 cites W2118611962 @default.
• W4366285248 cites W2127342819 @default.
• W4366285248 cites W2135589093 @default.
• W4366285248 cites W2149390058 @default.
• W4366285248 cites W2156231768 @default.
• W4366285248 cites W2156681954 @default.
• W4366285248 cites W2161804909 @default.
• W4366285248 cites W2166087533 @default.
• W4366285248 cites W2218250246 @default.
• W4366285248 cites W2256628135 @default.
• W4366285248 cites W2294312213 @default.
• W4366285248 cites W2552253622 @default.
• W4366285248 cites W2620957052 @default.
• W4366285248 cites W2623533890 @default.
• W4366285248 cites W2764093322 @default.
• W4366285248 cites W2889646458 @default.
• W4366285248 cites W2988499545 @default.
• W4366285248 cites W3043128098 @default.
• W4366285248 cites W4241062183 @default.
• W4366285248 doi "https://doi.org/10.3390/jcm12082916" @default.
• W4366285248 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37109252" @default.
• W4366285248 hasPublicationYear "2023" @default.
• W4366285248 type Work @default.
• W4366285248 citedByCount "0" @default.
• W4366285248 crossrefType "journal-article" @default.
• W4366285248 hasAuthorship W4366285248A5015775146 @default.
• W4366285248 hasAuthorship W4366285248A5015898602 @default.
• W4366285248 hasAuthorship W4366285248A5024817403 @default.
• W4366285248 hasAuthorship W4366285248A5059810021 @default.
• W4366285248 hasAuthorship W4366285248A5076128141 @default.
• W4366285248 hasAuthorship W4366285248A5078065507 @default.
• W4366285248 hasAuthorship W4366285248A5081409183 @default.
• W4366285248 hasBestOaLocation W43662852481 @default.
• W4366285248 hasConcept C121608353 @default.
• W4366285248 hasConcept C126322002 @default.
• W4366285248 hasConcept C126838900 @default.
• W4366285248 hasConcept C127077266 @default.
• W4366285248 hasConcept C144301174 @default.
• W4366285248 hasConcept C151956035 @default.
• W4366285248 hasConcept C167135981 @default.
• W4366285248 hasConcept C2775842073 @default.
• W4366285248 hasConcept C2776372563 @default.
• W4366285248 hasConcept C2777546739 @default.
• W4366285248 hasConcept C2779296616 @default.
• W4366285248 hasConcept C2780849966 @default.
• W4366285248 hasConcept C2780862961 @default.
• W4366285248 hasConcept C2989005 @default.
• W4366285248 hasConcept C3020375857 @default.
• W4366285248 hasConcept C38180746 @default.
• W4366285248 hasConcept C530470458 @default.
• W4366285248 hasConcept C71924100 @default.
• W4366285248 hasConceptScore W4366285248C121608353 @default.
• W4366285248 hasConceptScore W4366285248C126322002 @default.
• W4366285248 hasConceptScore W4366285248C126838900 @default.
• W4366285248 hasConceptScore W4366285248C127077266 @default.
• W4366285248 hasConceptScore W4366285248C144301174 @default.
• W4366285248 hasConceptScore W4366285248C151956035 @default.
• W4366285248 hasConceptScore W4366285248C167135981 @default.
• W4366285248 hasConceptScore W4366285248C2775842073 @default.
• W4366285248 hasConceptScore W4366285248C2776372563 @default.
• W4366285248 hasConceptScore W4366285248C2777546739 @default.
• W4366285248 hasConceptScore W4366285248C2779296616 @default.
• W4366285248 hasConceptScore W4366285248C2780849966 @default.
• W4366285248 hasConceptScore W4366285248C2780862961 @default.
• W4366285248 hasConceptScore W4366285248C2989005 @default.
• W4366285248 hasConceptScore W4366285248C3020375857 @default.
• W4366285248 hasConceptScore W4366285248C38180746 @default.
• W4366285248 hasConceptScore W4366285248C530470458 @default.
• W4366285248 hasConceptScore W4366285248C71924100 @default.

• next